PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0159069|impaired glucose tolerance |
| Sentences | 5 |
| PubMedID- 26313920 | Background: a number of epidemiological studies demonstrated that postprandial hyperglycemia is a risk factor for cardiovascular disease in individuals with impaired glucose tolerance. |
| PubMedID- 23777507 | Background and aims: asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase, is a biomarker and mediator of cardiovascular disease in patients with impaired glucose tolerance (igt) or diabetes mellitus (dm). |
| PubMedID- 21414227 | Post-prandial hyperglycemia and insulin resistance are thought to play a central role in the development and progression of cardiovascular disease in subjects with impaired glucose tolerance. |
| PubMedID- 21358541 | Background: the risk for cardiovascular disease almost increases in patients with impaired glucose tolerance compared with those with normal glucose tolerance. |
| PubMedID- 26242578 | However, there is an independent association of impaired glucose tolerance with cardiovascular diseases. |
Page: 1